Cancer imaging with radiolabeled antibodies: New advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan® and prospects for therapy

Journal of Nuclear Medicine Technology

Volumn 25, Issue 1, 1997, Pages 18-23

  Goldenberg, David M ^a   Juweid, Malik ^a   Dunn, Robert M ^a   Sharkey, Robert M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

Cancer; CEA; Immunoscintigraphy; Lymphoma; Radioimmunodetection

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TECHNETIUM 99M;

ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; HUMAN; IMAGING; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; RADIOIMMUNOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLONIC NEOPLASMS; DRUG APPROVAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; NEOPLASMS; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TECHNETIUM;

EID: 0030964441     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Goldenberg DM Monoclonal antibodies in cancer detection and therapy. Am J Med 1993;94:297-312.
2. Goidenberg DM Monoclonal antibody products: new advances J Biotechnol Healthcare 1996;2.112-422.
3. Moffat FL Jr, Pinsky CM, Hammershaimb L, et al. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab′ antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J Clin Oncol 1996; 14:2295-2305.
4. Goldenberg DM, DeLand F, Kim E, et al. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978;298:1384-1386.
5. Goldenberg DM, ed. Cancer imaging with radiolabeled antibodies Boston. Kluwer Academic Publishers; 1990.
6. Goldenberg TJ, Wlodkowski TM, Sharkey RM, et al. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med 1993;34:61-70.
7. Griffiths GL, Goldenberg DM, Jones AL, Hansen HJ. Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Biocondj Chem 1992;3:91-99.
8. 99mTc-labeling kit for antibody imaging. Cancer Res 1990;50.794s-798s.
9. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exper Med 1965;122.467-481.
10. Hansen HJ, Snyder JJ, Miller E, et al Carcinoembryonic antigen (CEA) assay A laboratory adjunct in the diagnosis and management of cancer Human Pathol 1974;5:139-147.
11. Van Nagell JR Jr, Donaldson ES, Wood EG, Goldenberg DM. The clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecologic malignancies. Cancer 1978;42:1527-1532.
12. Moore TL, Kantrowitz PA, Zamcheck N. Carcinoembryonic antigen (CEA) in inflammatory bowel disease. JAMA 1972;222.944-947.
13. Goldenberg DM, Sharkey RM, Primus FJ Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst 1976;57:11-22.
14. Sharkey RM, Hagihara PF, Goldenberg DM. Localization by immunoperoxidase and estimation by radioimmunoassay of carcinoembryonic antigen in colonic polyps. Br J Cancer 1977;35:179-189.
15. Mach JP, Carrell S, Merenda C, et al. In vivo localization of anti-CEA antibody in colon carcinoma: can the results obtained in the nude mice model by extrapolated to the patient situation? EurJ Cancer 1978;1:113-120.
16. Goldenberg DM, Kim EE, DeLand FH, Bennett S, Primus FJ. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980;40.2984-2992
17. Primus FJ, Goldenberg DM Immunological considerations on the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancer. Cancer Res 1980;40:2979-2983.
18. Goldenberg DM, Goldenberg H, Sharkey RM, et al. In vivo antibody imaging for the detection of human tumors. In: Goldenberg DM, ed. Cancer imaging with radiolabeled antibodies. Boston: Kluwer Academic Publishers: 1990:273-292.
19. Hughes K, Pinsky CM, Petrelh NJ, et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surg: in press.
20. Van Nagell JR Jr, Kim E, Casper S, et al. Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen. Cancer Res 1980;40:502-506
21. Goldenberg DM. Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies Am J Gastroenterol 1991;86:1392-1403.
22. Kramer EL, Noz ME, Liebes L, et al. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab′ fragment. preliminary results. Cancer 1994;73(suppl):890-895.
23. Gulec SA, Serafini AN, Moffat FL, et al. Radioimmunoscintigraphy of breast carcinoma using technetium-99m-labeled Fab′ fragment of anticarcinoembryonic antigen monoclonal antibody IMMU-4 (CEA-Scan ™). Dtagn Oncol 1994/95;4:209-213.
24. Rosner D, Abdel-Nabi H, Panaro V, Erb D, Wild L, Hreshchyshyn M. Immunoscintigraphy (IS) may reduce the number of surgical biopsies in women with benign breast disease (BBD) and indeterminate mammograms [Abstract]. Proc Am Soc Clin Oncol 1996;15.102
25. Juweid M, Sharkey RM, Behr T, et al. Improved detection of medullary thyroid cancer with radiolabeled monoclonal antibodies to carcinoembryonic antigen. J Clin Oncol 1996,14:1209-1217.
26. Stein R, Shin LB, Sharkey RM, Hansen HJ, Goldenberg DM. Immu-RAID™-LL2[Tc-99m] and ImmuRAIT™-LL2[I-131]. Drugs of the Future 1994;18:997-1004
27. Baum RP, Niesen A, Hertel A, et al Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the for radioimmunodetection of B-cell lymphomas. Cancer 1994,73(suppl):896-899.
28. 99mTc-labeled LL2 monoclonal antibody fragment. Cancer Res 1995;55.5764s-5770s.
29. 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma. Cancer Res 1995;55:5771s-5773s.
30. Goldenberg DM, Kim E, DeLand FH, et al. Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer 1980;45: 2500-2505.
31. Goldenberg DM, Goldenberg H, Higginbotham-Ford E. Imaging of primary and metastatic liver cancer with iodine-131 monoclonal and polyclonal antibodies against alphafetoprotein. J Clin Oncol 1987;5:1827-1835.
32. Goldenberg DM, Gaffar SA, Bennett SJ, Beach JL. Experimental radioimmunotherapy of a xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen. Cancer Res 1981;41:4354-4360.
33. Goldenberg DM, ed. Cancer therapy with radiolabeled antibodies. Boca Raton. FL: CRC Press: 1995.
34. Wilder RB, DeNardo GL. DeNardo SJ. Radioimmunotherapy: recent results and future directions. J Clin Oncol 1996,14:1383-1400.
35. Sharkey RM, Weadock KS, Natale A, et al. Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice. J Natl Cancer Inst 1991;83:627-632.
36. 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. Cancer Res 1990;50:1039s-1042s.
37. Juweid M, Sharkey RM, Behr T, et al. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med 1996,37:905-911.
38. 2. J Nucl Med 1996;37:1504-1510.
39. Behr TM, Sharkey RM, Juweid MI, et al. Factors influencing the pharmacokinetics, dosimetry and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of CEA-expressing tumors. Cancer Res 1996;56:1805-1816.
40. 131I-labeled anti-CEA monoclonal antibody. J Nucl Med 1997; in press.
41. Knox SJ. Radioimmunotherapy of the non-Hodgkin's lymphomas. Semin Radiat Oncol 1995;329.459-465.
42. Goldenberg DM, Horowitz JA, Sharkey RM, et al. Targeting, dosimetry and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol 1991;9:548-564.
43. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-1224.
44. 131I]anti-B1 (anti-CD20) antibody. N Engl J Med 1993;329: 459-465
45. 67Cu-21T-BAT-Lym-I and opportunities for improvement. In: Goldenberg DM. ed. Cancer therapy with radiolabeled antibodies. Boca Raton. FL: CRC Press; 1995:217-227.
46. Behr TM, Becker WS, Sharkey RM, et al. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J Nucl Med 1996; 37:29-33